2nd Quarter - Report

W STRATEGIES, LLC for ABBOTT LABORATORIES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R.5273: Helping Hospitals Improve Patient Care Act of 2016. H.R.5210: PADME Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5210 (114th), H.R. 5273 (114th)

Natural Resources NAT

H.R.5278: PROMESA Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5278 (114th)

Health Issues HCR

H.R. 1559/S. 764: Safe and Accurate Food Labeling Act of 2014. H.R. 6: 21st Century Cures Act. WHO Guidance on Promotion of Food for Infants and Children. FY 2017 House and Senate Agriculture Appropriations bills as it relates to regulation of laboratory developed tests.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th), H.R. 1559 (114th), S. 764 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.